v3.25.1
SHARE BASED COMPENSATION
3 Months Ended
Mar. 31, 2025
SHARE BASED COMPENSATION  
SHARE-BASED COMPENSATION

NOTE 10 – SHARE-BASED COMPENSATION

 

For share-based awards granted, we have recognized compensation expense based on the estimated grant date fair value method.  For these awards we have recognized compensation expense using a straight-line amortization method and reduced for estimated forfeitures.  

 

First quarter 2025 shared-based compensation of $174,000, was $107,000 lower compared to the prior year period due to staff reductions which occurred in the fourth quarter of 2024. The impact on our results of operations of recording share-based compensation, net of forfeitures, for the three months ended March 31, 2025 and 2024 were as follows:

 

 

 

 Three Months Ended

 

 

 

March 31,

2025

 

 

March 31,

2024

 

(in thousands)

 

 

 

 

 

 

Cost of goods sold

 

$25

 

 

$23

 

Research and development

 

 

48

 

 

 

65

 

Selling, general and administrative

 

 

101

 

 

 

193

 

Total share-based compensation

 

$174

 

 

$281

 

 

Equity awards granted during the three months ended March 31, 2025 and 2024 were as follows:

 

 

 

 Three Months Ended

 

 

 

March 31,

2025

 

 

March 31,

2024

 

 

 

 

 

 

 

 

Restricted Stock Units

 

 

10,000

 

 

 

-

 

 

Employee RSUs typically vest annually over three or four years and employee Non-Qualified stock options typically vest quarterly over four years and have a six-year exercise period. Non-employee director Restricted Stock Units (“RSUs”) typically vest over the earlier of one year or the next annual meeting of shareholders and Non-Qualified stock options vest over three years and have a six-year exercise period. 

 

Performance Stock Units (“PSUs”) typically cliff vest at the end of the performance period and the performance metric for 2023 awards is cumulative revenue growth over the three-year period ending December 31, 2025 with a cumulative revenue threshold, target, and maximum performance measure.  For 2024 awards, the performance metrics included revenue growth, EBITDA and project objective targets over the three-year period ending December 31, 2026. 

The remaining unamortized expected future equity compensation expense and remaining amortization period associated with award grants of RSUs, PSUs and unvested options at March 31, 2025 and 2024 are:

 

 

 

March 31,

2025

 

 

March 31,

2024

 

 

 

 

 

 

 

 

Unamortized future equity compensation expense (in thousands)

 

$1,237

 

 

$2,035

 

Remaining weighted average amortization period (in years)

 

 

2.21

 

 

 

2.29